로딩 중…
지수 로딩 중…
Bioventus Inc.
BVS· NASDAQ· Health Care· Health Care Equipment & Services
$13.47+2.28%
2026-08-03
Financials
Valuation Metrics
Bioventus Inc.'s Market Cap is $913M. At end of 2025 it was $496M. Ranked #2542 of 3,111 in US market (top 82%), #1054 of 1,445 on NASDAQ (top 73%), #157 of 206 in Health Care Equipment & Services (top 76%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $913M | US#2,542/3,111 Sec#157/206 |
| Revenue | $576M | US#2,281/3,111 Sec#143/206 |
| Net Income | $28M | US#2,021/3,111 Sec#92/206 |
| Total Assets | $651M | US#2,652/3,111 Sec#150/206 |
| Net Assets | $189M | US#2,760/3,111 Sec#167/206 |
| Value | ||
| P/E | 32.04x | US#1,515/3,111 Sec#56/206 |
| P/B | 4.83x | US#2,144/3,111 Sec#138/206 |
| P/S | 1.58x | US#1,015/3,111 Sec#70/206 |
| EV/EBITDA | 11.12x | US#917/3,111 Sec#30/206 |
| FCF Yield | 11.03% | US#408/3,111 Sec#13/206 |
| Profitability | ||
| ROE | 15.08% | US#861/3,111 Sec#39/206 |
| ROA | 4.38% | US#1,124/3,111 Sec#67/206 |
| Op. Margin | 10.64% | US#1,577/3,111 Sec#73/206 |
| Revenue Growth | 6.63% | US#1,583/3,111 Sec#113/206 |
| Financial Health | ||
| Debt Ratio | 220.37% | US#1,882/3,111 Sec#160/206 |
| Total Debt | $272M | US#2,105/3,111 Sec#109/206 |
| FCF | $101M | US#1,669/3,111 Sec#101/206 |
| Cash | $36M | US#2,718/3,111 Sec#180/206 |
| Current Ratio | 1.69x | US#1,499/3,111 Sec#135/206 |
| Net Debt/EBITDA | 2.29x | US#1,429/3,111 Sec#88/206 |
| Performance | ||
| 1Y Return | 117.96% | US#285/3,111 Sec#24/206 |
| 1M Return | 28.53% | US#26/3,111 Sec#6/206 |
| From 52W High | -3.44% | US#247/3,111 Sec#15/206 |
| 1Y MDD | -27.51% | US#1,184/3,111 Sec#39/206 |
| Trading | ||
| Volume | 1,109,330 shares | US#1,671/3,111 Sec#105/206 |
| Trading Value | $15M | US#2,298/3,111 Sec#152/206 |
| Per Share | ||
| EPS | $0.34 | US#1,916/3,111 Sec#100/206 |
| BPS | $2.76 | US#2,452/3,111 Sec#164/206 |